Figure 5.Gene alteration of CDK16. (A) The mutation and CNA status of CDK16 in TCGA-pan-cancer. (B) The correlation between CDK16 expression and CNA.
Figure 5 — CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers | Aging
